Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001462830-25-000001
Filing Date
2025-03-11
Accepted
2025-03-11 11:49:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11144
  Complete submission text file 0001462830-25-000001.txt   13073
Mailing Address 6295 NORTHAM DRIVE, UNIT 8 MISSISSAUGA, A6 L4V 1W8
Business Address 6865 SW 18TH STREET SUITE B13 BACA RATON FL 33433 905.673.8501
CardioGenics Holdings Inc. (Subject) CIK: 0001089029 (see all company filings)

EIN.: 880380456 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-57453 | Film No.: 25726495
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)

Mailing Address 303 EAST WACKER DRIVE SUITE 1040 CHICAGO IL 60601
Business Address 303 EAST WACKER DRIVE SUITE 1040 CHICAGO IL 60601 312-565-1569
Iliad Research & Trading, L.P. (Filed by) CIK: 0001462830 (see all company filings)

EIN.: 113688679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A